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Despite all the knowledge on depression, it is still unclear whether current literature covers all the psychosocial difficulties (PSDs)
important for depressed patients. The aim of the present study was to identify the gaps in the recent literature concerning
PSDs and their related variables. Psychosocial difficulties were defined according to the World Health Organization International
Classification of Functioning, Disability and Health (ICF). A comparative approach between a systematic literature review, a focus
group, and individual interviews with depressed patients was used. Literature reported the main psychosocial difficulties almost
fully, but not in the same degree of importance as patients’ reports. Furthermore, the covered areas were very general and related
to symptomatology. Regarding the related variables, literature focused on clinical variables and treatments above all but did not
report thatmany psychosocial difficulties influence other PSDs.This study identifiedmany existing research gaps in recent literature
mainly in the area of related variables of PSDs. Future steps in this direction are needed. Moreover, we suggest that clinicians select
interventions covering not only symptoms, but also PSDs and their modifiable related variables. Furthermore, identification of
interventions for particular psychosocial difficulties and personalisation of therapies according to individuals’ PSDs are necessary.
1. Introduction
Depression is amajor public health issue due to its prevalence,
highmortality rates [1], suicide risk [2], and economic impact
on the society [3]. It is considered to be the major cause of
years lived with disability (YLD) and by 2020 is expected
to be among the two main causes of disability adjusted
years (DALYs) together with ischemic heart disease [4]. The
functional limitations caused by depression are equal to or
even sometimes greater than the ones engendered by many
other chronic medical conditions [5]. In spite of the great
advances achieved in treatment of depression during the last
decades, between 20 and 30% of cases are not adequately
solved by first agent treatments (also known as treatment-
resistant depression in literature) [6].
This evidence suggests that usual management strategies
do not address sufficiently relevant areas of depression.
One substantial dimension of depression comprises the psy-
chosocial difficulties (PSDs) which people experience. PSDs
constitute the impairment on psychological and social daily
functioning of individuals, linked with their particular health
condition [7]. The broad range of PSDs encompasses not
only the personal, but also the economic and social impacts
of the disorder. Therefore, it is of extreme importance that
these psychosocial difficulties and their related variables are
analyzed accordingly. Such information can throw light on
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patients’ real needs, can help clinicians determine the areas in
depression that are to be improved and investigated further,
may help to prevent the onset of disability, and last, but
not least, may guide policy makers to design better health
policies.
Previous scientific literature provides different definitions
of psychosocial difficulties in depression but has some lim-
itations: the methods either focus only on specific areas or
consider the PSDs as a result of depression. Recent studies
[7–9], however, provide a new definition of PSDs, based on
WHO’s InternationalClassification of Functioning,Disability
and Health (ICF) [10]. This new approach covers the whole
course, determinants and onset of psychosocial problems,
and embodies an innovative holistic model of health. More
specifically, it states that PSDs are “. . .impairments of mental
functions, activity limitations and participation restrictions
that include both the individual’s mental capacities and
his or her social interactions (such as in work, family life
and leisure activities)” [7]. Moreover, impairments of body
functions under central nervous system control such as pain
and sexual interest problems are also included as PSDs. A
detailed description of the utility of the ICF classification for
depression can be found elsewhere [11].
Once this comprehensive definition of psychosocial dif-
ficulties has been extracted from the literature, it is very
important to incorporate the patient perspective in clinical
practice and research. The majority of studies on this topic
are quantitative; however, the literature that uses qualitative
methodologies—which could provide deeper, richer, and
more elaborated data, exploratory analyses on patients’ needs
and standpoints, and thus more objective results—is sparse.
Furthermore, this kind of studies can provide a general view
if particular psychosocial difficulties, named by patients as
important, are missing in the literature.
There are few existing studies using qualitative research to
identify a full list of PSDswhich depressed people experience.
Yet, none of them has applied a comprehensive approach
in order to encompass all the psychosocial difficulties from
different perspectives. An example is a study by Lasch et
al. [12], which aimed to develop a specific questionnaire to
assess symptoms for adult major depressive patients and to
track their functional status. The authors have conducted ten
focus groups and individual cognitive interviews and iden-
tified several general domains containing different concepts.
However, this study does not combine the patient perspective
with information from the literature.
An article by Bru¨tt et al. [13] based itself on a three-
dimensional design—systematic review of literature, patient
focus groups, and an expert panel aimed to identify a
core set of activities and participation for individuals with
mental disorders. Moreover, this research paper relied on
the International Classification of Functioning,Disability and
Health (ICF) as a conceptual framework for describing func-
tional impairments in patients. Despite the comprehensive
approach, the study has focused only on ICF categories of the
component activities and participation and has not taken into
account the other elements of the framework. Furthermore,
it has not included information regarding related variables of
psychosocial difficulties in depression.
To date, no study has analyzed the full set of PSDs
and their related variables in depression by including both
literature and patient perspective. The aim of the present
study is to tackle this research gap and discover whether the
recent scientific literature actually reports the PSDs and their
related variables that are important for depressed patients.
Our objective is to obtain information about whether the
latest literature extensively covers the issues that are pointed
out as problematic by depressed individuals, or if there are
particular areas, which should receive more attention. More-
over, a potential identification of these missing previously-
ignored questions in literature will enhance the quality of
future research and enable new strategies for treatment and
rehabilitation in depression.
2. Materials and Methods
In order to compare whether the psychosocial difficulties
experienced by depressed patients are actually reported by
recent literature in depression, we included a step by step
methodology.
2.1. Extraction of the Information. We gathered information
from three different studies.
2.1.1. Systematic Literature Review. First, a systematic review
to directly collect information reported in recent literature,
consulting the MEDLINE and PsycINFO databases, was
conducted. Search terms were adapted to each database
combining the MeSH headings of “Depression,” “Depressive
Disorder,” and “Depressive Disorder, Major” with “depress∗”
(title) in MEDLINE database and (DE=) “Major Depres-
sion,” “Recurrent Depression,” and “Depressive disorder”
in PsycINFO. For psychosocial difficulties the following
keywords were used: “psychosocial∗,” exp Quality of life/,
exp Personal satisfaction/exp Human activities/exp social
support/disabilit∗, homelessness, environmental factor∗, exp
Interpersonal relations/, exp Quality of life/, exp per-
sonal satisfaction/, exp human activities/, exp paternal-
ism/, prejudice/, psychosocial deprivation/, social values/,
exp Social Problems/, Social Adjustment/, social isola-
tion/stereotyping/, exp Social environment/, exp emotions/,
exp family/, exp socioeconomic factors/exp life style/exp
Disability evaluation/, exp Communication Barriers/, “Adap-
tation”, exp Psychological/, exp Aggression/, exp Psycho-
logical stress/, exp community (no microbial community)/,
Sexual∗ or intimacy. Inclusion criteria were articles reporting
information on psychosocial difficulties in people with a
diagnosis of major or minor depression according to DSM-
III-TR, DSM-IV, or DSM-IV-TR [14–16], or a depressive
episode or depressive disorders according to ICD-10 criteria
[17]. Qualitative articles and longitudinal observational and
interventional studies were also considered. Additional crite-
ria required the studies to be published in English between
2005 and 2010. Full results of the literature review can be
seen elsewhere [7]. Furthermore, studies were also excluded
if they were cross-sectional and psychometric or if they had
not included a standardized diagnosis of depression. Articles
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reporting patients with bipolar depression, dysthymia, or
postpartum depression were also excluded.
Once all the included studies were selected, we extracted
information about the sample characteristics and then col-
lected the variables, the tools, the psychosocial difficulties and
their related variables. Related variables in literature refer to
determinants of PSDs since only longitudinal studies were
included. Determinants in literature were those variables
that were longitudinal predictors for incidence or changing
of psychosocial difficulties, so consequently a causal rela-
tionship with the PSDs can be hypothesized. Extraction of
the information was double checked by two independent
reviewers in 20% of the articles (MC and BM) (Kappa =
0.80). Kappa’s coefficient was calculated according to Fleiss
and Cohen rules [20].
2.1.2. Focus Group. On the other hand, the collection of
patients’ perspectives was performed including information
from two studies. The first one consisted of one focus group
composed of seven depressed patients. We based our sample
size decisions on literature recommendations, “The ideal size
of a focus group formost noncommercial topics is five to eight
participants” [21] and the concern that a larger group could
make participants reserved or there would not be enough
time to hear everyone’s contribution. Inclusion criteria for
participating in the session were patients older than 18 years,
with a diagnosis of a depressive episode or a depressive
disorder according to ICD-10 during the last year. Eight
patients from the Hospital Universitario de la Princesa in
Madrid were invited to participate. Selection was done by
their main mental health care provider (psychiatrist) taking
into consideration the maximum variability of sampling in
gender, work status, and clinical status (totally remitted,
partially remitted, and nonremitted), consulting the patients’
clinical records. Eight patients were invited to participate
and one of them did not consent to participate reporting
having no time for this. Participation in this study was not
mandatory and only patients with motivation to participate
were included in the final sample; therefore a selection bias
could have affected our results. Participation was formally
agreed after signing a consent informed form.Onemoderator
and one assistant (MC and IL), who had been previously
trained, encouraged all themembers to participate during the
session.
Four open questions were posed: (1) which psychoso-
cial difficulties are usually experienced due to participant’s
depression; (2) which ones are more relevant (ranking the
five most important ones for each participant); (3) how
these difficulties changed overtime; and (4) which events are
responsible for the onset or change of these psychosocial
difficulties overtime. All the dialogues were digitally recorded
and subsequently transcribed.
2.1.3. Individual Interviews. Finally, in order to gather other
difficulties that are not usually reported during focus group
sessions because of potential unwillingness of self-disclosure
[22], we included data from 80 individual interviews. The
preselection of participants was done by their health care
providers (psychiatrist and GPs) according to the study
inclusion and exclusion criteria. All the patients that fulfilled
the inclusion criteria were invited to participate and pro-
videdbasic information (name and telephone) to researchers
to make an appointment. Only four patients did not agree
to participate. From these, two justifiedtheir denial with
the argument “I have no time to participate,” one had no
interest in research studies, and one showed no interest in
this particular study. During the initial interview researchers
verified the fulfillment of the inclusion criteria. At that point
five patients that were derived from the primary care center
were excluded because they met diagnostic criteria for other
different disorders: bipolar disorders (2), generalized anxiety
disorder (1), substance use disorder (1), and complicated grief
(𝑛 = 1) and thus satisfied one of the exclusion criteria.
Patients were singly asked, among other questions, which
were the five most disabling psychosocial difficulties that
they experienced due to depression and which were the
variables that were responsible for the onset or the change
of these problems. A causal relationship with the PSDs and
extraction of determinants, unlike in the literature, cannot
be established, because of the nature of the focus group and
the individual interviews; therefore we will refer to these
variables of onset or change of PSDs according to the patient
perspective as related variables.
Trained interviewers (MC, BM) conducted all the indi-
vidual interviews. Inclusion criteria for individual interviews
were patients older than 18 years with a diagnosis of depres-
sive episode or major depression criteria according to ICD-
10. All patients were collected in “Santa Hortensia” Primary
Care center of Madrid or in the outpatient psychiatric service
at the Hospital Universitario de la Princesa in Madrid. In
both study sites patients were chosen according to their
availability and were invited to participate by their primary
care doctors or psychiatrists. All participants signed an
informed consent form. Both studies were independently
reviewed and approved by the Hospital Ethics Committee for
Clinical Research.
2.2. Agreement on the Terminology to Describe PSDs and
Their Related Variables. After gathering information from
the three different studies, we needed to establish a com-
mon language necessary to directly compare outcomes. For
that purpose a list of common categories for classifying
psychosocial difficulties was agreed on during one research
group meeting. Participants were researchers who had been
involved in data collection for different health conditions.
Researchers involved in the data collection of depression (IL,
BM, and MC) also participated. All of them were requested
to share with the group the PSDs that they had identified in
the different studies and the terminology they had used to
name them. After each naming, the working group was asked
whether they agreed with the terminology proposed. After a
brief discussion, stating pros and cons for the proposal, an
agreed-on term was decided and documented for each PSD.
The same procedure was followed to extract the names of
related variables in subsequent working group sessions with
the same participants.
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2.3. Linking Process of Concepts. After obtaining the list of
common categories, we associated the different concepts
extracted in the studies to the agreed category list. For
personal factors we used the definition given by the WHO’s
International Classification of Functioning, Disability and
Health: “Personal factorsare the particular background of
an individual’s life and living, and comprise features of the
individual that are not part of a health condition or health
states. These factors may include gender, race, age, other
health conditions, fitness, lifestyle, habits, upbringing, coping
styles, social background, education, profession, past and
current experience (past life events and concurrent events),
overall behaviour pattern and character style, individual
psychological assets and other characteristics, all or any of
which may play a role in disability at any level. Personal
factors are not classified in ICF.” [10]. The liking process
was made by two independent researchers according to ICF
linking rules [23]. BM and MC participated in the linking
process for the focus group and literature review information
(Kappa = 0.92 and 0.88, resp.,) and KK and MC performed it
for individual interviews (Kappa = 0.85). Disagreements on
categories were solved consulting a third expert opinion.
2.4. Analysis of Data. Focusing on the information extracted
from the literature, a frequency analysis was performed
regarding how many different studies particularly reported
the psychosocial difficulties or related variables. In the case
of individual interviews, the number of times that the
different participants reported the psychosocial difficulties
and their related variables was calculated. Finally, for the
focus group, digital recordings were analyzed in order to
extract the number of times in which psychosocial difficulties
and related variables had been a topic during the session (i.e.,
number of times that these issues had been repeated by a
different participant). These analyses were performed with
the software for qualitative research NVIVO.
3. Results
3.1. Characteristics of the Participants in the Focus Group
and the Individual Interviews. Tables 1 and 2 show the
characteristics of the participants in the focus group and the
individual interviews.
3.2. Does Recent Literature Report the Main PSDs? Compari-
son between the literature review and the studies reporting
patient’s opinion showed that literature does cover almost
fully the main psychosocial difficulties directly addressed by
depressed individuals. There were relatively few PSDs, not
covered by the recent scientific literature. Table 3 summarizes
these outcomes.
Emotional functions [24–26], energy and drive functioning
[27–29], cognitive functions [30–32], employment [33–35],
and relationship with the others [36–38] were the most com-
mon psychosocial problems emerging both in the literature
and the patients’ answers.The frequency of the appearance of
PSDs was also comparatively identical.
However, somemain PSDs in the patient reports were not
covered enough by the literature. Carrying out daily routine
was pointed out by ten patients in the individual interviews
(making it the fifth most important PSD), but it has been
investigated less than three times in the revised literature.
Communication with others was among the most impor-
tant psychosocial problems, according to the participants
in the focus group, but our systematic review did not find
it mentioned anywhere in the literature. Moreover, weight
maintenance functions and doing houseworkwere highlighted
by the patients in the individual interviews, but literature
omitted them as significant and important psychosocial
difficulties in depression. In addition, there were some
main categories, which did not meet the same ranking of
significance when the different sources of information were
compared. Pain [39–41] and sleep [42, 43], for example,
were among the most important categories according to the
literature, but in the focus group and individual interviews
they were not emphasized notably by patients.
3.3. Specific PSDs. Regardless of these few above mentioned
PSDs, literature in general addresses substantially the main
psychosocial difficulties in depression. Therefore, we con-
ducted an elaborate second level analysis to investigate
whether the specific psychosocial difficulties (components
within the main PSD categories), reported in the focus
group and individual interviews, were also identified in the
literature. Once more, the results demonstrated that the
literature, with some exceptions, almost fully covers the range
of specific psychosocial difficulties, experienced by depressed
patients.
However, as can be seen in Table 4, some specific PSDs
were reported with different degrees of importance when
the three sources of information were compared. Loneliness
and distress (part of emotional functions) were among the
most important and commonly mentioned difficulties by
the patients, whereas these specific PSDs were reported less
than three times in the literature. The same is valid for
attention and memory (part of cognitive functions), efficiency
(employment), and intimate relationships (relationships with
others).
3.4. Does Recent Literature Report the Related Variables of
PSDs? Additionally, we investigated whether literature suffi-
ciently reports themost important related variables of change
and onset for psychosocial problems in depression that are
addressed by patients. All related variables can be seen in
Table 5. Literature reported only few related variables of onset
of PSDs. In fact, scientific literature reported clinical variables
and treatments above all. In contrast, the patients’ perspec-
tive, extracted by the focus group and individual interviews
we conducted, focused on how particular psychosocial dif-
ficulties lead to other PSDs. For instance, treatment [44–
46] was a related variable of change in several studies as
reported in literature, but participants in the focus group
identified it also as a related variable of onset for specific
PSDs. The same was valid for the role of the emotions in
change of PSDs, which was frequently indicated by literature,
BioMed Research International 5
Table 1: Characteristics of the participants in the focus group.
Case Gender Age Work status Comorbidity Mental health status
1 Female 51 Retired Fibromyalgia Partial remission
2 Male 44 Self-employed No Total remission
3 Male 50 Employed Hepatitis C Partial remission
4 Female 50 Disabled Cancer Depression
5 Male 49 Unemployed No Partial remission
6 Female 46 Disabled Arthrosis Total remission
7 Male 55 Retired No Depression
whereas patients reported these emotional functions as a
cause of psychosocial difficulties as well. Specifically, results
showed that the literature did not analyse sufficiently cognitive
functions, relationships with others, energy and drive, and
employment problems as causes of PSDs.
4. Discussion
The current study aimed to analyse whether the recent
scientific literature reports those psychosocial difficulties
and their related variables that are important for depressed
patients. Our findings indicated that the literature does report
almost fully the main psychosocial difficulties, experienced
by patients with depression, but the degree of importance
of each PSD depended on the source of information. The
same refers to the specific PSDs, extracted by a second level
analysis. Contrary to themain PSDs reported, however, only a
few related variables of onset of PSDs were currently reported
in literature. In addition, literaturewas specifically focused on
clinical variables as related to the PSDs, whereas it ignored
that some PSDs can also become related variables for other
PSDs.
To our knowledge, this is the first study to throw light
on whether the latest scientific literature actually reflects the
issues that are indicated as problematic by depressed patients.
However, all the subsequent comments on the literature have
to be considered with respect to the only 103 existing studies
within our period of search that covered the whole spectrum
of PSDs in depression and the fact that their average quality
rate is not high [7]. In this sense, this amount of articles seems
insufficient, since the literature review aimed to identify a list
of studies examining a wide range of psychosocial problems
in depression. It is not in the scope of the current paper to
elaborate on this deficit, but, given the present results, it is
important to mention that besides the existing information
gaps in the specialized publications, the quantity of adequate
studies addressing the most common difficulties and related
variables represents an additional limitation in the literature.
With regard to the most common psychosocial difficul-
ties, the literature and the patients’ outcomesmatched almost
entirely. Emotional functions stood out as an evident problem
for depressed patients, as part of the outcomes of 62 research
studies and being mentioned more than 100 times during the
focus group and individual interviews. A review by Brockow
et al. [47], based on the ICF classification, confirms the notion
that the emotional functioning is among the most affected
areas of depression. A second level analysis, conducted
to examine the specific segments of the main categories,
however, showed some discrepancies between the litera-
ture and the patients’ perspective. Incongruence regarding
depressive mood and symptoms [48–50] (being highlighted
in literature whereas downplayed by patients) or feelings
of loneliness and distress (emphasized notably by depressed
patients but narrowly explored in the literature) can be
explained through the literature tendency to focus mainly on
those PSDs which belong to the symptomatology spectrum.
In addition, according to our results, the literature usually
reported major PSD concepts. However, other more specific
and smaller categories, also highly affecting the emotional
functioning of individuals—like loneliness and distress—were
neglected.
The same applies to other groups like cognitive functions,
where research studies have focused on capital subcategories
of the main PSDs, such as cognitive functions in general,
thought functions, employment in general, or relationshipswith
the others in general, but have not elaborated on smaller
features. According to the present results, patients emphasize
the importance of the specific problem they experience, even
if it is very distinctive anddifferential.Therefore, the literature
should include adequate instruments to address these par-
ticular psychosocial issues and encompass the most delicate
and uncovered features of the psychosocial functioning of
individuals with depression.
Furthermore, another interesting discrepancy between
research and patient perspective regarding the consideration
of pain and sleep as important PSDscan be noticed. Both
problems have been frequently emphasized by different
research studies as essential for depression, while only few
participants in the focus group and individual interviews
mentioned them as important. One possible explanation
is the hiatus in people’s perceptions between depression
and physical symptoms. Although somatic symptoms are
a common feature of depression [51], a substantial per-
centage of patients, diagnosed with depression, understand
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Table 2: Characteristics of the participants in the individual
interviews.
Variables Setting
Specialized care Primary care
(𝑛 = 61, 75.3%) (𝑛 = 20, 24.7%)
Age (𝑛 = 61) (𝑛 = 20)
18–34 4 (6.6%) 4 (20.0%)
35–49 14 (23.0%) 6 (30.0%)
50–64 29 (47.0%) 5 (25.0%)
65+ 14 (23.0%) 5 (25.0%)
Gender
Female 50 (82.0%) 17 (85.0%)
Level of education
Less than primary school 11 (18.0%) 3 (15.0%)
Primary school
completed 9 (14.8%) 4 (20.0%)
Secondary school
completed 5 (8.2%) 4 (20.0%)
High School 10 (16.4%) 4 (20.0%)
University 20 (32.8%) 2 (10.0%)
Postgraduate studies
completed 6 (9.8%) 3 (15.0%)
Work situation
Working 14 (23.0%) 8 (40%)
Working (sick leave) 9 (14.7%) 1 (5.0%)
Unemployed 18 (29.5%) 4 (20.0%)
Homemaker 8 (13.1%) 4 (20.0%)
Student 1 (1.6%) —
Retired 7 (11.5%) 1 (5.0%)
Disability pension 3 (4.9%) —
Others 1 (1.6%) 2 (10.0%)
Number of previous
depressive episodes (𝑛 = 48) (𝑛 = 80)
0 (first episode) 7 (11.5%) 3 (15.0%)
1-2 26 (41.7%) 11 (55.0%)
+2 15 (24.5%) 2 (10.0%)
Self-administered
Comorbidity Questionnaire
(SCQ) [18], MD (SD)
12.8 (5.1) 11.8 (5.1)
Hamilton Depression
Rating Scale-17 (HDRS)∗
(𝑛 = 59) (𝑛 = 20)
Mild 4 (6.6%) 11 (55.0%)
Moderate 13 (21.3%) 8 (40.0%)
Severe 42 (68.9%) 1 (5.0%)
Suicide attempts (𝑛 = 57) (𝑛 = 19)
No 48 (78.7%) 15 (75.0%)
Yes 9 (14.8%) 4 (20.0%)
∗Cutoff points based on [19].
both as separate entities. Moreover, they frequently indicate
only physical symptoms as the reason for seeking medical
assistance [52]. Therefore, many depressed outpatients in
the present studies might have omitted some physical com-
plaints, disregarding any association between them and their
depressive condition. Another reason could be the nature
of the commonly used outcome instruments in depression
studies. Most of them, such as the Hamilton Rating Scale
for Depression (HRSD) [53], the Short Form Health Survey
(SF-36) [54], or the WHOQOL-100 [55], include physical
symptom items. Therefore, outcomes such as pain and sleep
disturbances are often included in scientific studies. Further
qualitative studies should confirmwhether or not these PSDs
are really important for depressed patients, because in that
case literature might be overestimating their relevance in
depression.
Regarding the related variables of PSDs, the results of
our analysis revealed interesting and alarming gaps in the
recent literature. Essentially, only few related variables of
onset of PSDs were reported in research. Emotional functions,
for example, being the leading related variable of onset for
participants in the focus group, have been considered only as
a determinant of change in literature. The same applies for
treatment. Depressed patients very often stated that the cause
of their PSDs was the type of treatment they received. As can
be extracted from literature, however, treatment is only able
to change the course of the disease (generally as a facilitator).
Literature should therefore consider the positive and negative
consequences of treatments on patient’s PSDs and not only
report the positive impact on them.This type of information
would be useful to help clinicians decide among the wide
range of interventions available.
On the other hand, current scientific literature con-
centrates on clinical variables and treatments as the only
PSDs’ related variables, whereas patients additionally high-
light the relationships between different PSDs. Specifically, if
the patient perspective is considered, literature on cognitive
functions, relationships with others, energy and drive, and
employment problems as related variables of PSDs would
have to be described as insufficient. These components
are fundamental to the understanding of the psychosocial
functioning of depressed patients.Hence, if the aim is to reach
a general development in this direction, future research needs
to focus on these gaps.
Overall, these findings reveal the fact that there is a
discrepancy between the patient’s and the health science
researchers’ perspective when analysing not only the bio-
logical and psychological factors of depression, but also the
socioeconomic and environmental variables. The subject’s
view of his health and functioning is not usually taken into
account when designing research studies in depression. In
this sense, future studies may address this wider view in a
more accurate way by taking into account additional sources
that are primarily focused on the subject and its sociological
environment. From a sociological point of view it could
be claimed that the mainstream perspective from which
most institutions and professionals develop their work is not
reflecting the quotidian environmental stressors that interfere
with an adaptive and healthy development of everyday life
in people with depression. It could be hypothesized that
this is a result of the current and most common definition
of depression through a list of symptoms facilitated by
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Table 3: Ranking of the main psychosocial difficulties according to literature and patient reports.
Literature review (number of studies) [ICF
code]
Focus group (number of times the PSDs
were a topic)
[ICF code]
Individual interviews (number of people)
[ICF code]
(1) Emotional functions (62) [b152]
(2) Pain (20) [b280–b289]
(3) Energy and drive (18) [b130, b640]
(4) Cognitive functions (17) [b140–b189,
b117]
(5) Employment (13) [d845–d859]
(6) Relationship with others (13) [d7]
(7) Self-care (12) [d5]
(8) Sleep (11) [b134]
(9) Temperament and personality functions
(10) [b126]
(10) Perception and experience of social
support (7) [pf]
(11) Participation in social activities (6)
[d920]
(12) Self-perception (6) [pf]
(13) Psychopathological symptoms (5) [b160,
b147, b152, b130]
(14) Mobility (5) [d4]
(15) Locus of control (4) [pf]
(16) Psychomotor functions (4) [b147]
(17) Driving (3) [d475]
(18) Perception and experience of stigma (3)
[pf]
(19) Self-efficacy (3) [pf]
(20) Coping strategies (3∗) [pf]
(1) Emotional functions (49) [b152]
(2) Cognitive functions (11) [b140–b189,
b117]
(3) Employment (11) [d845–d859]
(4) Perception and experience of social
support (9) [pf]
(5) Self-perception (9) [pf]
(6) Energy and drive (8) [b130, b640]
(7) Communication with others (7) [d350]
(8) Participating in social activities (6)
[d920]
(9) Relationship with others (6) [d7]
(10) Coping strategies (5) [pf]
(11) Psychopathological symptoms (4) [b160,
b147, b152, b130]
(12) Self-care (4) [d5]
(13) Carrying out daily activities (3) [d230]
(14) Perception and experience of stigma (3)
[pf]
(15) Sleep (3) [b134]
(1) Emotional functions (52) [b152]
(2) Energy and drive (31) [b130, b640]
(3) Relationship with others (24) [d7]
(4) Cognitive functions (23) [b140–b189,
b117]
(5) Carrying out daily routine (10) [d230]
(6) Self-perception (8) [pf]
(7) Pain (7) [b280–b289]
(8) Employment (6) [d845–d859]
(9) Participating in social activities (5)
[d920]
(10) Sleep (5) [b134]
(11) Weight maintenance functions (5)
[b530]
(12) Mobility (5) [d4]
(13) Doing housework (3) [d640, d630]
∗Only PSDs addressed more than three times in the literature or mentioned more than three times by the participants in the focus group and the individual
interviews are shown here.
Table 4: Ranking of the specific psychosocial difficulties according to literature and patient reports.
Main PSD categories Literature review (number of studies) Focus group(number of times thePSDs were a topic)
Individual interviews
(number of persons
mentioned the PSD)
Emotional functions
Depressive mood and symptoms (54)
Anxiety (8)
In general (5)
Emotional regulation (3∗)
In general (20)
Anxiety (10)
Depressive mood and symptoms (7)
Loneliness (6)
Distress (4)
Depressed mood (14)
Anxiety (14)
Emotional regulation (9)
Loneliness (8)
In general (5)
Cognitive functions
In general (5)
Thought functions (5)
Executive functions (3)
Thought functions (6)
Attention (3)
Attention (10)
Memory (7)
Employment In general (10) In general (11) Efficiency (5)In general (3)
Energy and Drive
Fatigue (8)
Vitality (7)
Libido (3)
Motivation (3)
In general (8)
Motivation(3)
In general (10)
Fatigue (9)
Family (10)
Relationship with
others
In general (6)
Family (5) In general (6)
Intimate relationships (9)
In general (4)
∗Only PSDs addressed more than three times in the literature or mentioned more than three times by the participants in the focus group and the individual
interviews are shown here.
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Table 5: Related variables of psychosocial difficulties in literature and patient reports.
Literature review (type of determinant and
number of studies)
Focus group (number of times PSD was a
topic)
Individual interviews (number of
people mentioned with PSD)
Patient treatment (DC∗) (26)
Health condition: symptoms (DC) (16)
Health condition: severity (DC) (8)
Temperament and personality (DC) (6)
Comorbidity (DC) (5)
Perception and experience of social support
(DC) (5)
Patient treatment ∗ treatment duration (DC) (4)
Emotional functions (DC) (3)
Overall score: ADL (DC) (3)
Health condition: duration of episode (DC) (3)
Stressful life events (DC) (3)
Stigma (DO) (3)
Self-perception (DO) (3∗∗)
Emotional functions (RVO) (18)
Stressful life events (RVO) (7)
Employment (RVO) (7)
Cognitive functions (RVO) (7)
Perception and experience of social support
(RVO) (6)
Energy and drive (RVO) (5)
Temperament and personality (RVO) (4)
Self-perception (RVO) (4)
Comorbidity (RVO) (4)
Patient treatment (RVC) (4)
Self-perception (RVO) (4)
Patient treatment (RVO) (3)
Relationship with others (RVC) (29)
Patient treatment (RVC) (23)
Emotional functions (RVC) (19)
Stressful life events (RVC) (7)
Health condition: symptoms (RVC) (7)
Attitudes (RVC) (7)
Comorbidity (RVC) (6)
Energy and drive (RVC) (6)
Self-perception (RVC) (5)
Coping strategies (RVC) (4)
Participation in social activities
(RVC) (4)
Ageing (RVC) (3)
Cognitive functions (RVC) (3)
Employment (RVC) (3)
∗DC, determinant of change; DO, determinant of onset; RVC, related variable of change; RVO, related variable of onset.
∗∗Only PSDs addressed more than three times in the literature or mentioned more than three times by the participants in the focus group and the individual
interviews are shown here.
established diagnostic manuals: the DSM and ICD. They are
based on passive categorical labelling (mainly by health care
professionals), which list a number of prototype behaviours
that could occur if certain psychological problems occur.
This conceptualization within the medical model does not
take into account the life circumstances and biographical
context, which the individual interacts with, and thus the
psychological sense that provides the key to understanding
how this problem has been generated and why it remains is
disregarded.
The ICF model has been created by WHO as a comple-
mentary tool to the diagnostic systems (DSM and ICD) to
describe the day-to-day functioning of people. Within the
ICF model, psychosocial difficulties are seen as a continuum
and as a result of the complex interaction of environmental
variables, mental functions, personal variables, activities and
participation, and health status. Another option for person-
alization of medicine and treatment in real clinical settings
might be the inclusion of evaluations of daily functional
problems experienced by patients. Therefore we suggest cus-
tomization of healthcare—with therapeutic decisions being
tailored to the individual patient. The diagnostic testing has
to be adjusted accordingly for selecting appropriate therapies.
Eventually, engagement of patients in identifying specific
personal problems (e.g., dysfunctional patterns of emotional,
cognitive, and behavioural reactivity to natural environments
in daily life) could provide more personalized informa-
tion and change the pattern of diagnosing. For example,
ecological momentary assessments of patients via different
technologies, eventual self-monitoring, or even more collab-
orative interactions with therapists and professional carers
would enhance research in this direction and give us a new
insight. Recent literature based on ecological momentary
assessments (EMA) gives us promising results in this line.
Different studies [56, 57] have found the experience of pos-
itive affect to be prominent in resilience against depression
and to predict recovery [58]. Depression has been found to
influence work performance with significant decrease in task
focus and productivity [59]. Evidence shows that patients
with major depressive disorder experience fewer positive
events and perceive them as more stressful [60]. Among
adolescents, depressive symptoms have been found related to
less effective emotion regulation [61]. The EMA have been
implemented in research not only on depression, but also on
schizophrenia, anxiety, ADHD, bipolar disorder, and so forth.
Ecological momentary assessments have been initially
used to identify moment-to-moment patterns and mecha-
nisms of psychopathology [62], but with the development of
technologies and especially web based applications, real-life
data become available to patients and clinicians, making the
transformation of implicit real-life patterns into explicit ones
possible, thus improving personalized mental health care
[63].Themethod has been recently successfully implemented
in studies, aiming to explore whether self-monitoring can
also be used as an intervention to increase patients’ insights
in personalized patterns of positive affect [64]. The EMA
approach is just one promising way of overcoming the
discrepancy between the patient’s and the health science
researchers’ perspective when analysing the variety of factors
for depression. Its aim is not to replace the traditional face-
to-face contact with practitioners but to allow patients to take
an active role in their recovery process and to personalize the
treatment process.
Moreover, the patient perspective on PSDs and their
related variables has also an impact on the clinical arena.
Results of this study highlight the need for change and
adjustment of future strategies for treatment and rehabilita-
tion in depression. The process could be more productive,
when clinicians select interventions covering PSDs and their
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modifiable determinants or related variables, and not only
symptoms. Solving some activity problems, for example, can
help in improving other areas as well. Furthermore, per-
sonalization of therapies according to individuals’ PSDs will
enhance the treatment process. In general, identification of
specific interventions for particular psychosocial difficulties
is necessary and future research should address this issue.
4.1. Limitations. The findings of this study, however, have
to be interpreted assuming its limitations. First, only one
focus group of seven patients was performed and saturation
point—considering the quantity of information regarding
the analysed PSDs—was not reached; therefore the focus
group can be considered by some as nonrepresentative. As a
partial solution we included a heterogeneous group through
maximum sampling variation regarding sex, working status,
and clinical status. The age range, however, was between 44
and 55 years, which might have caused a potential bias in
the identification of PSDs. This is an important limitation,
since some psychosocial difficulties, usually experienced in
particular ages, like physical pain in older adults, or problems
with intimate relationships or loss of life goals in younger
adults, might have been omitted by the nonpresence of
representatives of these age groups in our focus group.
During the selection process, the psychiatrists who were
responsible for the recruitment of participants took into
consideration the maximum variability of sampling, but the
time frame and the profile of patients in the catchment
area of the Hospital Universitario de la Princesa in general
did not allow us to have a more representative sample in
terms of age. However, we decided to proceed with the
focus group, because, in fact, a more homogeneous sample of
participants is often preferable in terms of age, since it might
increase the group comfort level when discussing sensitive
topics. Therefore we could assess a wide variety of PSDs
including sexual problems, relationships with the therapist,
and somatic problems. Finally, in order to achieve more
reliable results, we conducted individual interviews with 80
patients ranging substantially in terms of age.Thereat, in spite
of this limitation, we found a high variability of PSDs and the
valuable finding about the discrepancies between literature
and patient reports. Further studies reaching saturation
points should be done to test if there are other underexplored
PSDs.
Second, a limited period of time was included for the
literature search (studies between 2005 and 2010).The search
was performed over papers published within the cited period
of time because of temporal limitations and because we were
interested in the recent literature outcomes rather than gen-
eral literature. However, we made replication of the original
search from 2011 to September 2013 in order to check if any
newPSDswill occur in comparisonwith the initial search and
the results did not identify newPSDs.The results of the review
have to be read in light of the limitations due to the type
of databases consulted. This review study was a component
of a larger project that gathered psychosocial factors from
severalmental health and neurological conditionswhere only
Medline and PsycINFO were included. As a consequence, an
amount of studies might have not been identified. As a limi-
tation concerning the reliability of the extraction process we
have to indicate that only 20% of articles were independently
double checked. Finally, by limiting our search to English
literature, we might have omitted relevant papers in other
languages.
5. Conclusions
The present study is, to our knowledge, the first to analyse
the full set of psychosocial difficulties and their related
variables in depression through the literature and the patient
perspective. We made an elaborate comparison between
both sources of information in order to verify whether
recent research literature reported all the PSDs and related
variables that are important for depressed patients and to
identify the existing gaps in this area. Regarding the research
on depression, the results obtained within our study show
the existence of many literature gaps and encourage future
studies to focus on them more in depth. Concerning the
clinical implications, this study emphasizes the need for
change and adjustment of future strategies for treatment and
rehabilitation in depression.We suggest that clinicians should
select interventions that cover PSDs and their modifiable
related variables and not only improve symptoms. Further-
more, eventual identification and personalization of therapies
according to individuals’ PSDs would potentially enhance the
rehabilitation process.
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